STa Pharma (600079.SH) has submitted an application for the issuance of A-shares to specific targets, which has been accepted by the Shanghai Stock Exchange.

Zhito Finance APP news, ST Renfu (600079.SH) announced that on August 3, 2026, it received a notice from the Shanghai Stock Exchange (referred to as "SSE") regarding the acceptance of Renfu Pharmaceutical Group Co., Ltd.'s application for issuing securities as a listed company on the Shanghai main board. The SSE has verified the fundraising memorandum and related application documents submitted by the company based on relevant regulations, and found that the application documents are complete and compliant with legal forms. Therefore, it decided to accept the application and conduct a review according to the law.